Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SANBU Stock Summary
In the News
SANBU Financial details
Company Rating
Buy
Market Cap
0
Income
6.79M
Revenue
0
Book val./share
-0.4
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0.03
Forward P/E
-
PEG
-
P/S
-
P/B
-0.02
P/C
-
P/FCF
-
Quick Ratio
0.32
Current Ratio
0.32
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.35
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-96.55%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
1.36%
Inst Trans
0.28%
ROA
3%
ROE
-58%
ROC
0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.595-10.69
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
644
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
SANBU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-06-30
Metric | History | 2022-06-30 |
---|---|---|
2.02K | ||
Revenue per share | 0 | |
Net income per share | 0.2 | |
Operating cash flow per share | -0.04 | |
Free cash flow per share | -0.04 | |
Cash per share | 0.01 | |
Book value per share | -0.34 | |
Tangible book value per share | 7.47 | |
Share holders equity per share | -0.34 | |
Interest debt per share | 0 | |
Market cap | 225.15M | |
Enterprise value | 224.89M | |
P/E ratio | 51.47 | |
Price to sales ratio | 0 | |
POCF ratio | -225.44 | |
PFCF ratio | -225.44 | |
P/B Ratio | -29.33 | |
PTB ratio | -29.33 | |
EV to sales | 0 | |
Enterprise value over EBITDA | 51.04 | |
EV to operating cash flow | -225.19 | |
EV to free cash flow | -225.19 | |
Earnings yield | 0.02 | |
Free cash flow yield | 0 | |
Debt to equity | 0 | |
Debt to assets | 0 | |
Net debt to EBITDA | -0.06 | |
Current ratio | 0.65 | |
Interest coverage | 0 | |
Income quality | -0.23 | |
Dividend Yield | 0 | |
Payout ratio | 0 | |
Sales general and administrative to revenue | 0 | |
Research and developement to revenue | 0 | |
Intangibles to total assets | 0 | |
Capex to operating cash flow | 0 | |
Capex to revenue | 0 | |
Capex to depreciation | 0 | |
Stock based compensation to revenue | 0 | |
Graham number | 1.23 | |
ROIC | -0.57 | |
Return on tangible assets | 0.02 | |
Graham Net | -0.37 | |
Working capital | -280.35K | |
Tangible asset value | 167.41M | |
Net current asset value | -8M | |
Invested capital | 0 | |
Average receivables | 0 | |
Average payables | 0 | |
Average inventory | 0 | |
Days sales outstanding | 0 | |
Days payables outstanding | 0 | |
Days of inventory on hand | 0 | |
Receivables turnover | 0 | |
Payables turnover | 0 | |
Inventory turnover | 0 | |
ROE | -0.57 | |
Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q4
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0.24 | 0.11 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | -0.04 | -0.02 | |
Free cash flow per share | 0 | 0 | 0 | -0.04 | -0.02 | |
Cash per share | 0.01 | 0.01 | 0 | 0.03 | 0.01 | |
Book value per share | 0 | 0 | 0 | -0.41 | -0.4 | |
Tangible book value per share | 0 | 0 | 0.01 | 8.8 | 8.81 | |
Share holders equity per share | 0 | 0 | 0 | -0.41 | -0.4 | |
Interest debt per share | 0.01 | 0.01 | -0.13 | 0 | 0.13 | |
Market cap | 221.33M | 221.33M | 188.7M | 190.13M | 190.89M | |
Enterprise value | 221.32M | 221.5M | 188.7M | 189.62M | 190.64M | |
P/E ratio | -4.7K | -9.9K | 10.14 | 22.98 | 659.93 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -807.79K | -13.77K | -372.87K | -273.75 | -663.8 | |
PFCF ratio | -807.79K | -13.77K | -372.87K | -273.75 | -663.8 | |
P/B Ratio | 16.74K | 29.02K | -19.22K | -24.54 | -24.87 | |
PTB ratio | 16.74K | 29.02K | -19.22K | -24.54 | -24.87 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -18.79K | -39.61K | 84.29 | 91.67 | 1.82K | |
EV to operating cash flow | -807.75K | -13.78K | -372.87K | -273.02 | -662.92 | |
EV to free cash flow | -807.75K | -13.78K | -372.87K | -273.02 | -662.92 | |
Earnings yield | 0 | 0 | 0.02 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 22.69 | 39.33 | 0 | 0 | 0 | |
Debt to assets | 0.75 | 0.89 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.95 | -30.3 | 0 | -0.25 | -2.41 | |
Current ratio | 0.81 | 4.73 | 5.75 | 2.54 | 0.65 | |
Interest coverage | 0 | 1.12K | 0.07 | 0 | 1.04 | |
Income quality | 0.02 | 2.87 | 0 | -0.34 | -3.98 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0.05 | 1 | 0.19 | |
ROIC | -0.04 | -0.02 | 36.59 | -0.27 | -0.23 | |
Return on tangible assets | -0.03 | -0.02 | 26.39 | 0.01 | 0 | |
Graham Net | 0 | -0.01 | 0 | -0.43 | -0.43 | |
Working capital | -75.33K | 102.97K | 752.62 | 476.77K | -280.35K | |
Tangible asset value | 13.22K | 7.63K | 165.43K | 167.34M | 167.41M | |
Net current asset value | -75.33K | -197.03K | -9.84K | -7.89M | -8M | |
Invested capital | 22.69 | 39.33 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 6.35K | 806 | 91.41K | 397.74K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.89 | -0.73 | -473.74 | -0.27 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SANBU Frequently Asked Questions
What is Sanaby Health Acquisition Corp. I stock symbol ?
Sanaby Health Acquisition Corp. I is a US stock , located in Palo alto of Ca and trading under the symbol SANBU
What is Sanaby Health Acquisition Corp. I stock quote today ?
Sanaby Health Acquisition Corp. I stock price is $- today.
Is Sanaby Health Acquisition Corp. I stock public?
Yes, Sanaby Health Acquisition Corp. I is a publicly traded company.